Quanex Q1 net loss of $14.9 million; sales rise 67% to $400.0 million on Tyman
Quanex reported a fiscal first-quarter net loss of $14.9 million, or $0.32 per diluted share, versus net income of $6.2 million, or $0.19 per share, a year earlier, while net sales rose 67.3% to $400.0 million on the Tyman acquisition. The company reaffirmed its fiscal 2025 guidance of $1.84 billion to $1.86 billion in net sales and $270 million to $280 million in Adjusted EBITDA, and it said it has repaid $65 million of debt since closing the Tyman deal on August 1, 2024.
Key points
- Net sales were $400.0 million for the three months ended January 31, 2025, up from $239.2 million; Tyman contributed $175.7 million, and excluding Tyman, net sales declined 6.2%.
- Net loss was $14.9 million, or $0.32 per diluted share, compared with net income of $6.2 million, or $0.19 per share; restructuring charges were $7.9 million.
- Adjusted diluted EPS was $0.19, down from $0.25, and Adjusted EBITDA was $38.5 million, up from $19.3 million.
- Fiscal 2025 guidance was reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million; total debt was $764.3 million as of January 31, 2025.
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 10, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.